Influence of different physicochemical conditions on the release of indium oxine from nanocapsules

Journal of Biomedical Materials Research

Volumn 39, Issue 4, 1998, Pages 588-593

  Kedzierewicz, F ^a   Thouvenot, P ^b   Monot, I ^a   Hoffman, M ^a   Maincent, P ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Esterases; In vitro release kinetics; Indium oxine; Polyepsiloncaprolactone nanocapsules

Indexed keywords

BIODEGRADATION; CATALYST ACTIVITY; DIALYSIS; EMULSIONS; ENZYMES; INDIUM COMPOUNDS; MOLECULAR WEIGHT; ORGANIC POLYMERS; PH EFFECTS; RADIOACTIVE TRACERS; REACTION KINETICS; VEGETABLE OILS;

INDIUM OXINE; NANOCAPSULES; POLYEPSILONCAPROLACTONE;

DRUG PRODUCTS;

8 QUINOLINOL INDIUM IN 111; ESTERASE; NANOCAPSULE; OLIVE OIL;

ARTICLE; DEGRADATION; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SYNTHESIS; GEL PERMEATION CHROMATOGRAPHY; KINETICS; MOLECULAR WEIGHT; PARTICLE SIZE; PARTITION COEFFICIENT;

DOSAGE FORMS; DRUG CARRIERS; ESTERASES; HYDROGEN-ION CONCENTRATION; MOLECULAR WEIGHT; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; PARTICLE SIZE; POLYESTERS;

EID: 0032521101     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19980315)39:4<588::AID-JBM13>3.0.CO;2-3     Document Type: Article

References (16)

1. Marchal-Heussler, D. Sirbat, M. Hoffman, and P. Maincent, "Poly(ε-caprolactone) nanocapsules in carteolol ophthalmic delivery," Pharm. Res., 3, 386-390 (1993).
2. L. Marchal-Heussler, H. Fessi, J. P. Devissaguet, M. Hoffman, and P. Maincent, "Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: Polyisobutylcyanoacrylate, polylactic-co-glycolic acid, polyepsilon-caprolactone," S.T.P. Pharm. Sci., 2, 98-104 (1992).
3. B. Hubert, J. Atkinson, M. Guerret, M. Hoffman, J. P. Devissaguet, and P. Maincent, "The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker," Pharm. Res., 8, 734-738 (1991).
4. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, "Nanocapsule formation by interfacial polymer deposition following solvent displacement," Int. J. Pharmaceutics, 55, R1-R4 (1989).
5. M. Thakur, R. Coleman, and M. Welch, "Indium-111-labeled leukocytes for the localization of abscess: Preparation, analysis, tissue distribution and comparison with gallium-67 citrate in dogs," J. Lab. Clin. Med., 89, 217-228 (1977).
6. S. J. Holland, B. J. Tighe, and P. L. Gould, "Polymers for biodegradable medical devices. I. The potential of polyesters as controlled macromolecular release systems," J. Controlled Release, 4, 155-180 (1986).
7. C. Washington, "Drug release from microdisperse systems: A critical review," Int. J. Pharmaceutics, 58, 1-12 (1990).
8. N. Ammoury, H. Fessi, J. P. Devissaguet, F. Puisieux, and S. Benita, "In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules," J. Pharmaceut. Sci., 79, 763-767 (1990).
9. B. C. Thanoo, W. J. Doll, R. C. Mehta, G. A. Digenis, and P. P. DeLuca, "Biodegradable Indium-111-labeled microspheres for in vivo evaluation of distribution and elimination," Pharm. Res., 12, 2060-2064 (1995).
10. M. D. Coffin and J. W. McGinity, "Biodegradable pseudolatexes: The chemical stability of poly (D,L-lactide) and poly (ε-caprolactone) nanoparticles in aqueous media," Pharm. Res., 9, 200-205 (1992).
11. A. Schindler and C. G. Pitt, "Biodegradable elastomeric polyesters," Polym. Prep., 23, 111-112 (1982).
12. A. Belbella, C. Vauthier, H. Fessi, J. P. Devissaguet, and F. Puisieux, "In vitro degradation of nanospheres from poly (D,L-lactides) of different molecular weights and polydispersities," Int. J. Pharmaceutics, 129, 95-102 (1996).
13. D. Scherer, J. R. Robinson, and J. Kreuter, "Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles," Int. J. Pharmaceutics, 101, 165-168 (1994).
14. H. Fukuzaki, M. Yoshida, M. Asano, M. Kumakura, T. Mashimo, H. Yuasa, K. Imai, H. Yamanaka, U. Kawaharada, and K. Suzuki, "A new biodegradable pasty-type copolymer of L-lactic acid and δ-valerolactone with relatively low molecular weight for application in drug delivery systems," J. Controlled Release, 10, 293-303 (1989).
15. C. G. Pitt, G. L. Kimmel, J. Surles, and A. Schindler, "Alphatic polyesters. II. The degradation of poly(DL-lactide), poly(ε-caprolactone), and their copolymers in vivo," Biomaterials, 2, 215-220 (1981).
16. S. C. Woodward, P. S. Brewer, F. Moatamed, A. Schindler, and C. G. Pitt, "The intracellular degradation of poly(ε-caprolactone)," J. Biomed. Mater. Res., 19, 437-444 (1985).